Follow
QuiaPEG Pharmaceuticals Holding AB
Nasdaq First North GM (Sweden)
QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to improve and develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Sector:
HEALTH CARE
>
Pharmaceuticals, Biotechnology & Life Sciences
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
QUIA
SE0001384850
Nasdaq First North GM
Sweden (SE)
Details of share in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA
Status
Active
Order book id
40YR
Amount of instruments
53 658 594
Par value
0.9000
Market cap
121 800 000.00 SEK
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
21 Jun 2005
Direct listing of QuiaPEG Pharmaceuticals Holding AB on Spotlight
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
14 Sep - 04 Oct 2006
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
1.85 SEK
38.9M SEK
01 Nov - 01 Nov 2017
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
1.75 SEK
27 Apr 2018
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
3.40 SEK
01 Feb 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
3.55 SEK
17 Jul 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.75 SEK
56.4M SEK
25 Jun - 09 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
New issue
2.41 SEK
88.2M SEK
13 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Market move
2.41 SEK
21 Aug 2020
Listing of QuiaPEG Pharmaceuticals Holding AB on Nasdaq First North GM
Type
Ticker
ISIN
Market
OPTION
QUIA TO4
SE0014429239
Nasdaq First North GM
Sweden (SE)
Details of option in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA TO4
Status
Active
Order book id
200628
Amount of instruments
5 365 859
Market cap
Currency
SEK
Segment
First North
Trading period
21 Aug 2020 - 15 Feb 2021
Terms
Each warrant entitles the holder to subscribe for one (1) new share in the Company during the period 20 January 2021 through 17 February 2021 at a subscription price corresponding to 70 percent of the volume weighted average price for the Company's share during the period of ten (10) trading days ending one (1) banking day before the first day of the redemption period. However, the exercise price should not be less than SEK 1.0.
Update (04.08.2020): QuiaPEG's rights issue registered - conversion of BTU into shares and warrants and admission to trading of warrants.
Update (12.08.2020): QuiaPEG Pharmaceuticals Holding AB will be delisted after close of the market on August 20, 2020.
Type
Price
Pre-money valuation
Time
Files
Exercise
20 Jan - 17 Feb 2021
Option exercise terms for QUIA TO4
Type
Ticker
ISIN
Market
SHARE
VISY
SE0001384850
Nasdaq First North GM
Sweden (SE)
Details of share in QuiaPEG Pharmaceuticals Holding AB with ticker VISY
Status
Archived
Order book id
30329
Amount of instruments
Par value
Market cap
Currency
SEK
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
21 Jun 2005
Direct listing of QuiaPEG Pharmaceuticals Holding AB on Spotlight
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
14 Sep - 04 Oct 2006
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Ticker
ISIN
Market
SHARE
QUIA
SE0001384850
Nasdaq First North GM
Sweden (SE)
Details of share in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA
Status
Active
Order book id
40YR
Amount of instruments
53 658 594
Par value
0.9000
Market cap
121 800 000.00 SEK
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Files
Targeted issue
1.85 SEK
38.9M SEK
01 Nov - 01 Nov 2017
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
1.75 SEK
27 Apr 2018
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
3.40 SEK
01 Feb 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
3.55 SEK
17 Jul 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.75 SEK
56.4M SEK
25 Jun - 09 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
New issue
2.41 SEK
88.2M SEK
13 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Market move
2.41 SEK
21 Aug 2020
Listing of QuiaPEG Pharmaceuticals Holding AB on Nasdaq First North GM
Type
Ticker
ISIN
Market
OPTION
QUIA TO4
SE0014429239
Nasdaq First North GM
Sweden (SE)
Details of option in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA TO4
Status
Active
Order book id
200628
Amount of instruments
5 365 859
Market cap
Currency
SEK
Segment
First North
Trading period
21 Aug 2020 - 15 Feb 2021
Terms
Each warrant entitles the holder to subscribe for one (1) new share in the Company during the period 20 January 2021 through 17 February 2021 at a subscription price corresponding to 70 percent of the volume weighted average price for the Company's share during the period of ten (10) trading days ending one (1) banking day before the first day of the redemption period. However, the exercise price should not be less than SEK 1.0.
Update (04.08.2020): QuiaPEG's rights issue registered - conversion of BTU into shares and warrants and admission to trading of warrants.
Update (12.08.2020): QuiaPEG Pharmaceuticals Holding AB will be delisted after close of the market on August 20, 2020.
Type
Price
Pre-money valuation
Time
Files
Exercise
20 Jan - 17 Feb 2021
Option exercise terms for QUIA TO4
People
Marcus Bosson
CEO
Steen Krøyer
Chairman of the board
Christian Krog-Jensen
Board member
Johan von Kantzow
Board member
Jonas Jarvius
Board member
Lars Linzander
Board member
Marcus Bosson
Board member
Marek Kwiatkowski
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Virdings Allé 32 B
Zip code
754 50
City/district
Uppsala
Country
Sweden (SE)
Registration number
556658-0196
LEI code
967600JUP7EI6X9D2Z44
First trade date
21 Jun 2005
Registration date
25 Mar 2004
Short name
QuiaPEG Pharmaceuticals

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date